Life SciencesPharmaceuticalsVaccines

MENA Regions (Middle East and North Africa) Foot and Mouth Disease (FMD) Vaccines Market Report 2018

Lowest Prices Guaranteed Length Publisher Published Date SKU
from $4,000 162 Pages QYResearch Group May, 2018 QYR15695695
Lowest Prices Guaranteed
Price from $4,000
Length 162 Pages
Publisher QYResearch Group
Published Date May, 2018
SKU QYR15695695

MENA Regions (Middle East and North Africa) Foot and Mouth Disease (FMD) Vaccines Market Report 2018

This report studies the Foot and Mouth Disease (FMD) Vaccines market status and outlook of MENA and major countries, from angles of players, countries, product types and end industries; this report analyzes the top players in MENA and major countries, and splits the Foot and Mouth Disease (FMD) Vaccines market by product type and applications/end industries.

The Foot and Mouth Disease (FMD) Vaccines are expected to grow at a CAGR of 6.97% from 8.248 million USD in 2017 to reach 14.146 million USD by 2025 in MENA market. The Foot and Mouth Disease (FMD) Vaccines market is very concerted market; the revenue of top nine manufacturers accounts about 93.5% of the total revenue in 2017. The high-end products mainly come from Europe and Middle East.

The leading players mainly are BVI, VSVRI, RVSRI, NVI and Boehringer Ingelheim. BVI is the largest players; its revenue of MENA market exceeds 26% in 2017. The next is VSVRI and RVSRI.

The major players in MENA Foot and Mouth Disease (FMD) Vaccines market include
BVI
VSVRI
RVSRI
NVI
Boehringer Ingelheim
ME VAC
VETAL
Biopharma
MSD Animal Health

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Foot and Mouth Disease (FMD) Vaccines in these regions, from 2013 to 2025 (forecast), covering
Egypt
KSA
Qatar
Oman
UAE
Kuwait
Bahrain
Sudan
Other

On the basis of product, the Foot and Mouth Disease (FMD) Vaccines market is primarily split into
Emergency Vaccines
Conventional Vaccines


On the basis on the end users/applications, this report covers
Cattle
Sheep & Goat
Other


1 Foot and Mouth Disease (FMD) Vaccines Overview 1
1.1 Product Overview and Scope of Foot and Mouth Disease (FMD) Vaccines 1
1.2 Classification of Foot and Mouth Disease (FMD) Vaccines by Product Category 2
1.2.1 MENA Foot and Mouth Disease (FMD) Vaccines Sales Comparison by Types (2013-2025) 2
1.2.2 MENA Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Types in 2017 2
1.2.3 Emergency Vaccines 3
1.2.4 Conventional Vaccines 3
1.3 MENA Foot and Mouth Disease (FMD) Vaccines Market by Applications/End Users 4
1.3.1 MENA Foot and Mouth Disease (FMD) Vaccines Sales and Market Share Comparison by Applications (2013-2025) 4
1.3.2 Cattle 5
1.3.3 Sheep & Goat 5
1.4 MENA Foot and Mouth Disease (FMD) Vaccines Market by Regions 6
1.4.1 MENA Foot and Mouth Disease (FMD) Vaccines Revenue Comparison by Regions (2013-2025) 6
1.4.2 Egypt Foot and Mouth Disease (FMD) Vaccines Status and Prospect (2013-2025) 6
1.4.3 KSA Foot and Mouth Disease (FMD) Vaccines Status and Prospect (2013-2025) 7
1.4.4 Qatar Foot and Mouth Disease (FMD) Vaccines Status and Prospect (2013-2025) 8
1.4.5 UAE Foot and Mouth Disease (FMD) Vaccines Status and Prospect (2013-2025) 8
1.4.6 Kuwait Foot and Mouth Disease (FMD) Vaccines Status and Prospect (2013-2025) 9
1.4.7 Bahrain Foot and Mouth Disease (FMD) Vaccines Status and Prospect (2013-2025) 10
1.4.8 Oman Foot and Mouth Disease (FMD) Vaccines Status and Prospect (2013-2025) 11
1.4.9 Sudan Foot and Mouth Disease (FMD) Vaccines Status and Prospect (2013-2025) 11
1.5 MENA Sales and Revenue of Foot and Mouth Disease (FMD) Vaccines (2013-2025) 12
1.5.1 MENA Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) and Growth Rate (2013-2025) 12
1.5.2 MENA Foot and Mouth Disease (FMD) Vaccines Revenue (K USD) and Growth Rate (2013-2025) 13
2 MENA Foot and Mouth Disease (FMD) Vaccines Competition by Players, Type and Application 15
2.1 MENA Foot and Mouth Disease (FMD) Vaccines Market Competition by Players 15
2.1.1 MENA Foot and Mouth Disease (FMD) Vaccines Sales and Market Share by Players (2017-2018) 15
2.1.2 MENA Foot and Mouth Disease (FMD) Vaccines Revenue and Market Share by Players (2013-2018) 17
2.2 MENA Foot and Mouth Disease (FMD) Vaccines Sales and Revenue by Type 19
2.2.1 MENA Foot and Mouth Disease (FMD) Vaccines Sales and Market Share by Type (2013-2018) 19
2.2.2 MENA Foot and Mouth Disease (FMD) Vaccines Revenue and Market Share Type (2013-2018) 21
2.3 MENA Foot and Mouth Disease (FMD) Vaccines Sales and Revenue by Regions 23
2.3.1 MENA Foot and Mouth Disease (FMD) Vaccines Sales and Market Share by Regions (2013-2018) 23
2.3.2 MENA Foot and Mouth Disease (FMD) Vaccines Revenue and Market Share Regions (2013-2018) 25
2.4 MENA Foot and Mouth Disease (FMD) Vaccines Sales by Application 27
3 Egypt Foot and Mouth Disease (FMD) Vaccines (Sales, Revenue and Price) 30
3.1 Egypt Foot and Mouth Disease (FMD) Vaccines Sales and Revenue (2013-2018) 30
3.1.1 Egypt Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2013-2018) 30
3.1.2 Egypt Foot and Mouth Disease (FMD) Vaccines Revenue and Growth Rate (2013-2018) 31
3.1.3 Egypt Foot and Mouth Disease (FMD) Vaccines Sales Price Trend (2013-2018) 32
3.2 Egypt Foot and Mouth Disease (FMD) Vaccines Sales and Market Share by Type 32
3.3 Egypt Foot and Mouth Disease (FMD) Vaccines Sales and Market Share by Applications 33
4 Sudan Foot and Mouth Disease (FMD) Vaccines (Sales, Revenue and Price) 35
4.1 Sudan Foot and Mouth Disease (FMD) Vaccines Sales and Revenue (2013-2018) 35
4.1.1 Sudan Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2013-2018) 35
4.1.2 Sudan Foot and Mouth Disease (FMD) Vaccines Revenue and Growth Rate (2013-2018) 36
4.1.3 Sudan Foot and Mouth Disease (FMD) Vaccines Sales Price Trend (2013-2018) 37
4.2 Sudan Foot and Mouth Disease (FMD) Vaccines Sales and Market Share by Type 37
4.3 Sudan Foot and Mouth Disease (FMD) Vaccines Sales and Market Share by Applications 38
5 KSA Foot and Mouth Disease (FMD) Vaccines (Sales, Revenue and Price) 40
5.1 KSA Foot and Mouth Disease (FMD) Vaccines Sales and Revenue (2013-2018) 40
5.1.1 KSA Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2013-2018) 40
5.1.2 KSA Foot and Mouth Disease (FMD) Vaccines Revenue and Growth Rate (2013-2018) 41
5.1.3 KSA Foot and Mouth Disease (FMD) Vaccines Sales Price Trend (2013-2018) 42
5.2 KSA Foot and Mouth Disease (FMD) Vaccines Sales and Market Share by Type 42
5.3 KSA Foot and Mouth Disease (FMD) Vaccines Sales and Market Share by Applications 43
6 UAE Foot and Mouth Disease (FMD) Vaccines (Sales, Revenue and Price) 45
6.1 UAE Foot and Mouth Disease (FMD) Vaccines Sales and Revenue (2013-2018) 45
6.1.1 UAE Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2013-2018) 45
6.1.2 UAE Foot and Mouth Disease (FMD) Vaccines Revenue and Growth Rate (2013-2018) 46
6.1.3 UAE Foot and Mouth Disease (FMD) Vaccines Sales Price Trend (2013-2018) 47
6.2 UAE Foot and Mouth Disease (FMD) Vaccines Sales and Market Share by Type 47
6.3 UAE Foot and Mouth Disease (FMD) Vaccines Sales and Market Share by Applications 48
7 Qatar Foot and Mouth Disease (FMD) Vaccines (Sales, Revenue and Price) 50
7.1 Qatar Foot and Mouth Disease (FMD) Vaccines Sales and Revenue (2013-2018) 50
7.1.1 Qatar Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2013-2018) 50
7.1.2 Qatar Foot and Mouth Disease (FMD) Vaccines Revenue and Growth Rate (2013-2018) 51
7.1.3 Qatar Foot and Mouth Disease (FMD) Vaccines Sales Price Trend (2013-2018) 52
7.2 Qatar Foot and Mouth Disease (FMD) Vaccines Sales and Market Share by Type 52
7.3 Qatar Foot and Mouth Disease (FMD) Vaccines Sales and Market Share by Applications 53
8 Oman Foot and Mouth Disease (FMD) Vaccines (Sales, Revenue and Price) 55
8.1 Oman Foot and Mouth Disease (FMD) Vaccines Sales and Revenue (2013-2018) 55
8.1.1 Oman Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2013-2018) 55
8.1.2 Oman Foot and Mouth Disease (FMD) Vaccines Revenue and Growth Rate (2013-2018) 56
8.1.3 Oman Foot and Mouth Disease (FMD) Vaccines Sales Price Trend (2013-2018) 57
8.2 Oman Foot and Mouth Disease (FMD) Vaccines Sales and Market Share by Type 57
8.3 Oman Foot and Mouth Disease (FMD) Vaccines Sales and Market Share by Applications 58
9 Kuwait Foot and Mouth Disease (FMD) Vaccines (Sales, Revenue and Price) 60
9.1 Kuwait Foot and Mouth Disease (FMD) Vaccines Sales and Revenue (2013-2018) 60
9.1.1 Kuwait Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2013-2018) 60
9.1.2 Kuwait Foot and Mouth Disease (FMD) Vaccines Revenue and Growth Rate (2013-2018) 61
9.1.3 Kuwait Foot and Mouth Disease (FMD) Vaccines Sales Price Trend (2013-2018) 62
9.2 Kuwait Foot and Mouth Disease (FMD) Vaccines Sales and Market Share by Type 62
9.3 Kuwait Foot and Mouth Disease (FMD) Vaccines Sales and Market Share by Applications 63
10 Bahrain Foot and Mouth Disease (FMD) Vaccines (Sales, Revenue and Price) 65
10.1 Bahrain Foot and Mouth Disease (FMD) Vaccines Sales and Revenue (2013-2018) 65
10.1.1 Bahrain Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2013-2018) 65
10.1.2 Bahrain Foot and Mouth Disease (FMD) Vaccines Revenue and Growth Rate (2013-2018) 66
10.1.3 Bahrain Foot and Mouth Disease (FMD) Vaccines Sales Price Trend (2013-2018) 67
10.2 Bahrain Foot and Mouth Disease (FMD) Vaccines Sales and Market Share by Type 67
10.3 Bahrain Foot and Mouth Disease (FMD) Vaccines Sales and Market Share by Applications 68
11 Analysis of Foot and Mouth Disease (FMD) Vaccines Industry Key Manufacturers 70
11.1 BVI 70
11.1.1 Company Profile 70
11.1.2 Product Information 71
11.1.3 Sales, Price, Cost, Gross, and Revenue 71
11.2 VSVRI 72
11.2.1 Company Profile 72
11.2.2 Product Information 72
11.2.3 Sales, Price, Cost, Gross, and Revenue 74
11.3 RVSRI 74
11.3.1 Company Profile 74
11.3.2 Product Information 75
11.3.3 Sales, Price, Cost, Gross, and Revenue 75
11.4 NVI 76
11.4.1 Company Profile 76
11.4.2 Product Information 77
11.4.3 Sales, Price, Cost, Gross, and Revenue 78
11.5 Boehringer Ingelheim 78
11.5.1 Company Profile 78
11.5.2 Product Information 79
11.5.3 Sales, Price, Cost, Gross, and Revenue 79
11.6 ME VAC 80
11.6.1 Company Profile 80
11.6.2 Product Information 81
11.6.3 Sales, Price, Cost, Gross, and Revenue 81
11.7 VETAL 81
11.7.1 Company Profile 81
11.7.2 Product Information 82
11.7.3 Sales, Price, Cost, Gross, and Revenue 83
11.8 Biopharma 83
11.8.1 Company Profile 83
11.8.2 Product Information 84
11.8.3 Sales, Price, Cost, Gross, and Revenue 84
11.9 MSD Animal Health 85
11.9.1 Company Profile 85
11.9.2 Product Information 86
11.9.3 Sales, Price, Cost, Gross, and Revenue 87
12 Foot and Mouth Disease (FMD) Vaccines Manufacturing Cost Analysis 88
12.1 Foot and Mouth Disease (FMD) Vaccines Key Raw Materials Analysis 88
12.1.1 Key Raw Materials 88
12.1.2 Key Suppliers of Raw Materials 88
12.2 Proportion of Manufacturing Cost Structure 89
12.2.1 Raw Materials 89
12.2.2 Labor Cost 89
12.2.3 Other Costs Analysis 96
12.3 Manufacturing Process Analysis of Foot and Mouth Disease (FMD) Vaccines 100
13 Industrial Chain, Sourcing Strategy and Downstream Buyers 101
13.1 Foot and Mouth Disease (FMD) Vaccines Industrial Chain Analysis 101
13.2 Upstream Raw Materials Sourcing 102
13.3 Downstream Buyers 102
14 Marketing Strategy Analysis, Distributors/Traders 104
14.1 Marketing Channel 104
14.1.1 Direct Marketing 104
14.1.2 Indirect Marketing 104
14.1.3 Marketing Channel Development Trend 104
14.2 Market Positioning 105
14.2.1 Pricing Strategy 105
14.2.2 Brand Strategy 106
14.3 Distributors/Traders List 107
15 Market Effect Factors Analysis 109
15.1 Impact of FMD 109
15.2 Regulatory Environment of FMD 110
15.3 Consumer Needs/Customer Preference Change 111
15.4 Economic/Political Environmental Change 111
16 MENA Foot and Mouth Disease (FMD) Vaccines Market Forecast (2019-2025) 120
16.1 MENA Foot and Mouth Disease (FMD) Vaccines Sales, Revenue Forecast (2019-2025) 120
16.1.1 MENA Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate Forecast (2019-2025) 120
16.1.2 MENA Foot and Mouth Disease (FMD) Vaccines Revenue (K USD) and Growth Rate Forecast (2019-2025) 121
16.2 MENA Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Growth Rate Forecast by Regions (2019-2025) 121
16.2.1 MENA Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate Forecast by Regions (2019-2025) 121
16.2.2 MENA Foot and Mouth Disease (FMD) Vaccines Revenue and Growth Rate Forecast by Regions (2019-2025) 123
16.2.3 Egypt Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Growth Rate Forecast (2019-2025) 125
16.2.4 Qatar Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Growth Rate Forecast (2019-2025) 126
16.2.5 KSA Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Growth Rate Forecast (2019-2025) 127
16.2.6 UAE Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Growth Rate Forecast (2019-2025) 128
16.2.7 Kuwait Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Growth Rate Forecast (2019-2025) 129
16.2.8 Bahrain Foot and Mouth Disease (FMD) Vaccines Sales (K Doses), Revenue (K USD) and Growth Rate Forecast (2019-2025) 130
16.2.9 Oman Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Growth Rate Forecast (2019-2025) 131
16.2.10 Sudan Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Growth Rate Forecast (2019-2025) 132
16.3 MENA Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Price Forecast by Type (2019-2025) 133
16.3.1 MENA Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Type (2019-2025) 133
16.3.2 MENA Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Type (2019-2025) 134
16.3.3 MENA Foot and Mouth Disease (FMD) Vaccines Price Forecast by Type (2019-2025) 135
16.4 MENA Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Application (2019-2025) 135
17 Research Findings and Conclusion 137
18 Methodology and Data Source 138
18.1 Methodology/Research Approach 138
18.1.1 Research Programs/Design 138
18.1.2 Market Size Estimation 139
18.1.3 Market Breakdown and Data Triangulation 140
18.2 Data Source 141
18.2.1 Secondary Sources 141
18.2.2 Primary Sources 142
18.3 Disclaimer 143
18.4 Author List 144
List of Tables and Figures
Figure Product Picture of Foot and Mouth Disease (FMD) Vaccines 1
Table MENA Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) and Revenue (K USD) Comparison by Types (2013-2025) 2
Figure MENA Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Types in 2017 2
Figure Emergency Vaccines Product Picture 3
Figure Conventional Vaccines Product Picture 3
Table MENA Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) Comparison by Applications (2013-2025) 4
Figure MENA Sales Market Share of Foot and Mouth Disease (FMD) Vaccines by Applications in 2017 4
Figure Cattle Examples 5
Figure Sheep & Goat Examples 5
Table MENA Market Foot and Mouth Disease (FMD) Vaccines Revenue (K USD) Comparison by Regions 2013-2025 6
Figure Egypt Foot and Mouth Disease (FMD) Vaccines Revenue (K USD) and Growth Rate (2013-2025) 7
Figure KSA Foot and Mouth Disease (FMD) Vaccines Revenue (K USD) and Growth Rate (2013-2025) 7
Figure Qatar Foot and Mouth Disease (FMD) Vaccines Revenue (K USD) and Growth Rate (2013-2025) 8
Figure UAE Foot and Mouth Disease (FMD) Vaccines Revenue (K USD) and Growth Rate (2013-2025) 9
Figure Kuwait Foot and Mouth Disease (FMD) Vaccines Revenue (K USD) and Growth Rate (2013-2025) 10
Figure Bahrain Foot and Mouth Disease (FMD) Vaccines Revenue (K USD) and Growth Rate (2013-2025) 10
Figure Oman Foot and Mouth Disease (FMD) Vaccines Revenue (K USD) and Growth Rate (2013-2025) 11
Figure Sudan Foot and Mouth Disease (FMD) Vaccines Revenue (K USD) and Growth Rate (2013-2025) 12
Figure MENA Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) and Growth Rate (2013-2025) 13
Figure MENA Foot and Mouth Disease (FMD) Vaccines Revenue (K USD) and Growth Rate (2013-2025) 14
Table MENA Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) by Players (2017-2018) 15
Table MENA Foot and Mouth Disease (FMD) Vaccines Sales Share by Players (2017-2018) 15
Figure 2017 MENA Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Players 16
Figure 2018 MENA Foot and Mouth Disease (FMD) Vaccines Sales Share by Players 17
Table MENA Foot and Mouth Disease (FMD) Vaccines Revenue (K USD) by Players (2017-2018) 17
Table MENA Foot and Mouth Disease (FMD) Vaccines Revenue Market Share Players (2017-2018) 18
Figure 2017 MENA Foot and Mouth Disease (FMD) Vaccines Revenue Market Share Players 18
Figure 2018 MENA Foot and Mouth Disease (FMD) Vaccines Revenue Market Share Players 19
Table MENA Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) and Market Share by Type (2013-2018) 19
Table MENA Foot and Mouth Disease (FMD) Vaccines Sales Share by Type (2013-2018) 20
Figure Sales Market Share of Foot and Mouth Disease (FMD) Vaccines by Type (2013-2018) 20
Figure MENA Foot and Mouth Disease (FMD) Vaccines Sales Growth Rate by Type (2013-2018) 21
Table MENA Foot and Mouth Disease (FMD) Vaccines Revenue (K USD) and Market Share Type (2013-2018) 21
Table MENA Foot and Mouth Disease (FMD) Vaccines Revenue Market Share Type (2013-2018) 21
Figure Revenue Market Share of Foot and Mouth Disease (FMD) Vaccines by Type (2013-2018) 22
Figure MENA Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate by Type (2013-2018) 23
Table MENA Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) and Market Share by Regions (2013-2018) 23
Table MENA Foot and Mouth Disease (FMD) Vaccines Sales Share by Regions (2013-2018) 24
Figure Sales Market Share of Foot and Mouth Disease (FMD) Vaccines by Regions (2013-2018) 24
Figure MENA Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Regions in 2017 25
Table MENA Foot and Mouth Disease (FMD) Vaccines Revenue (K USD) and Market Share by Regions (2013-2018) 25
Table MENA Foot and Mouth Disease (FMD) Vaccines Revenue Share by Regions (2013-2018) 26
Figure Revenue Market Share of Foot and Mouth Disease (FMD) Vaccines by Regions (2013-2018) 26
Figure MENA Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Regions in 2017 27
Table MENA Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) and Market Share by Application (2013-2018) 27
Table MENA Foot and Mouth Disease (FMD) Vaccines Sales Share by Application (2013-2018) 27
Figure MENA Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2013-2018) 28
Figure MENA Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2013-2018) 29
Figure Egypt Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) and Growth Rate (2013-2018) 30
Figure Egypt Foot and Mouth Disease (FMD) Vaccines Revenue (K USD) and Growth Rate (2013-2018) 31
Figure Egypt Foot and Mouth Disease (FMD) Vaccines Sales Price (USD/K Doses) Trend (2013-2018) 32
Table Egypt Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) by Type (2013-2018) 32
Table Egypt Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) Market Share by Type (2013-2018) 33
Figure Egypt Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type in 2017 33
Table Egypt Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) by Applications (2013-2018) 33
Table Egypt Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Applications (2013-2018) 34
Figure Egypt Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Applications in 2017 34
Figure Sudan Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) and Growth Rate (2013-2018) 35
Figure Sudan Foot and Mouth Disease (FMD) Vaccines Revenue (K USD) and Growth Rate (2013-2018) 36
Figure Sudan Foot and Mouth Disease (FMD) Vaccines Sales Price (USD/K Doses) Trend (2013-2018) 37
Table Sudan Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) by Type (2013-2018) 37
Table Sudan Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) Market Share by Type (2013-2018) 38
Figure Sudan Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type in 2017 38
Table Sudan Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) by Applications (2013-2018) 38
Table Sudan Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Applications (2013-2018) 39
Figure Sudan Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Applications in 2017 39
Figure KSA Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) and Growth Rate (2013-2018) 40
Figure KSA Foot and Mouth Disease (FMD) Vaccines Revenue (K USD) and Growth Rate (2013-2018) 41
Figure KSA Foot and Mouth Disease (FMD) Vaccines Sales Price (USD/K Doses) Trend (2013-2018) 42
Table KSA Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) by Type (2013-2018) 42
Table KSA Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) Market Share by Type (2013-2018) 43
Figure KSA Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type in 2017 43
Table KSA Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) by Applications (2013-2018) 43
Table KSA Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Applications (2013-2018) 44
Figure KSA Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Applications in 2017 44
Figure UAE Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) and Growth Rate (2013-2018) 45
Figure UAE Foot and Mouth Disease (FMD) Vaccines Revenue (K USD) and Growth Rate (2013-2018) 46
Figure UAE Foot and Mouth Disease (FMD) Vaccines Sales Price (USD/K Doses) Trend (2013-2018) 47
Table UAE Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) by Type (2013-2018) 47
Table UAE Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) Market Share by Type (2013-2018) 48
Figure UAE Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type in 2017 48
Table UAE Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) by Applications (2013-2018) 48
Table UAE Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Applications (2013-2018) 49
Figure UAE Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Applications in 2017 49
Figure Qatar Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) and Growth Rate (2013-2018) 50
Figure Qatar Foot and Mouth Disease (FMD) Vaccines Revenue (K USD) and Growth Rate (2013-2018) 51
Figure Qatar Foot and Mouth Disease (FMD) Vaccines Sales Price (USD/K Doses) Trend (2013-2018) 52
Table Qatar Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) by Type (2013-2018) 52
Table Qatar Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) Market Share by Type (2013-2018) 53
Figure Qatar Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type in 2017 53
Table Qatar Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) by Applications (2013-2018) 53
Table Qatar Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Applications (2013-2018) 54
Figure Qatar Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Applications in 2017 54
Figure Oman Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) and Growth Rate (2013-2018) 55
Figure Oman Foot and Mouth Disease (FMD) Vaccines Revenue (K USD) and Growth Rate (2013-2018) 56
Figure Oman Foot and Mouth Disease (FMD) Vaccines Sales Price (USD/K Doses) Trend (2013-2018) 57
Table Oman Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) by Type (2013-2018) 57
Table Oman Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) Market Share by Type (2013-2018) 58
Figure Oman Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type in 2017 58
Table Oman Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) by Applications (2013-2018) 58
Table Oman Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Applications (2013-2018) 59
Figure Oman Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Applications in 2017 59
Figure Kuwait Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) and Growth Rate (2013-2018) 60
Figure Kuwait Foot and Mouth Disease (FMD) Vaccines Revenue (K USD) and Growth Rate (2013-2018) 61
Figure Kuwait Foot and Mouth Disease (FMD) Vaccines Sales Price (USD/K Doses) Trend (2013-2018) 62
Table Kuwait Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) by Type (2013-2018) 62
Table Kuwait Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) Market Share by Type (2013-2018) 63
Figure Kuwait Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type in 2017 63
Table Kuwait Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) by Applications (2013-2018) 63
Table Kuwait Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Applications (2013-2018) 64
Figure Kuwait Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Applications in 2017 64
Figure Bahrain Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) and Growth Rate (2013-2018) 65
Figure Bahrain Foot and Mouth Disease (FMD) Vaccines Revenue (K USD) and Growth Rate (2013-2018) 66
Figure Bahrain Foot and Mouth Disease (FMD) Vaccines Sales Price (USD/K Doses) Trend (2013-2018) 67
Table Bahrain Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) by Type (2013-2018) 67
Table Bahrain Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) Market Share by Type (2013-2018) 68
Figure Bahrain Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type in 2017 68
Table Bahrain Foot and Mouth Disease (FMD) Vaccines Sales (K Doses) by Applications (2013-2018) 68
Table Bahrain Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Applications (2013-2018) 69
Figure Bahrain Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Applications in 2017 69
Table BVI Company Profile 70
Figure Foot and Mouth Disease (FMD) Vaccines Product Picture of BVI 71
Table Foot and Mouth Disease (FMD) Vaccines Sales (K Doses), Price (USD/K Doses), Cost (USD/K Doses), Gross (USD/K Doses), Revenue (K USD) and Gross Margin of BVI 2017-2018 71
Table VSVRI Company Profile 72
Table Foot and Mouth Disease (FMD) Vaccines Product of VSVRI 72
Table Foot and Mouth Disease (FMD) Vaccines Sales (K Doses), Price (USD/K Doses), Cost (USD/K Doses), Gross (USD/K Doses), Revenue (K USD) and Gross Margin of VSVRI 2017-2018 74
Table RVSRI Company Profile 74
Figure Foot and Mouth Disease (FMD) Vaccines Product Picture of RVSRI 75
Table Foot and Mouth Disease (FMD) Vaccines Sales (K Doses), Price (USD/K Doses), Cost (USD/K Doses), Gross (USD/K Doses), Revenue (K USD) and Gross Margin of RVSRI 2017-2018 75
Table NVI Company Profile 76
Figure Foot and Mouth Disease (FMD) Vaccines Product Picture of NVI 77
Table Foot and Mouth Disease (FMD) Vaccines Sales (K Doses), Price (USD/K Doses), Cost (USD/K Doses), Gross (USD/K Doses), Revenue (K USD) and Gross Margin of NVI 2017-2018 78
Table Boehringer Ingelheim Company Profile 78
Figure Foot and Mouth Disease (FMD) Vaccines Product Picture of Boehringer Ingelheim 79
Table Foot and Mouth Disease (FMD) Vaccines Sales (K Doses), Price (USD/K Doses), Cost (USD/K Doses), Gross (USD/K Doses), Revenue (K USD) and Gross Margin of Boehringer Ingelheim 2017-2018 79
Table ME VAC Company Profile 80
Figure Foot and Mouth Disease (FMD) Vaccines Product Picture of ME VAC 81
Table Foot and Mouth Disease (FMD) Vaccines Sales (K Doses), Price (USD/K Doses), Cost (USD/K Doses), Gross (USD/K Doses), Revenue (K USD) and Gross Margin of ME VAC 2017-2018 81
Table VETAL Company Profile 81
Figure Foot and Mouth Disease (FMD) Vaccines Product Picture of VETAL 82

$4,000
$8,000

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks